Literature DB >> 22573725

Understanding smokers' motivations to use evidence-based smoking cessation aids.

Roy A Willems1, Marc C Willemsen, Gera E Nagelhout, Hein de Vries.   

Abstract

INTRODUCTION: Use of evidence-based smoking cessation aids (SCA) is an efficacious way to improve smoking cessation relapse rates. However, use of SCA in the Netherlands is particularly low. This study examined determinants of intention to use SCA in smokers willing to quit.
METHODS: The Dutch Continuous Survey of Smoking Habits, a cross-sectional population survey, was used. Respondents were smokers (n = 594) wanting to quit sometime in the future and who made at least one quit attempt in the past, categorized as past users of evidence-based SCA, past users of nonevidence-based SCA, and smokers who had never used SCA before (nonusers). Respondents were asked about past SCA use, motivational determinants regarding smoking cessation and SCA use, and intention to use SCA during a future quit attempt.
RESULTS: Older and more addicted smokers were more likely to have used evidence-based SCA. Evidence-based and nonevidence-based users reported stronger attitudes and perceived social norm as well as lower self-efficacy expectations regarding smoking cessation and SCA use than nonusers. Having positive outcome expectations and perceived social norm regarding SCA use were strong predictors of intention to use SCA. Self-efficacy regarding smoking cessation was negatively related with intention to use SCA.
CONCLUSIONS: Nonusers, nonevidence-based users, and evidence-based users have different motivations for using evidence-based SCA and should not be treated as a homogenous group in smoking cessation programs. Additionally, it is unclear whether nonusers should be encouraged to use SCA, given that this group is less addicted and more confident about quitting.

Entities:  

Mesh:

Year:  2012        PMID: 22573725     DOI: 10.1093/ntr/nts104

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  7 in total

1.  Are there income differences in the impact of a national reimbursement policy for smoking cessation treatment and accompanying media attention? Findings from the International Tobacco Control (ITC) Netherlands Survey.

Authors:  Gera E Nagelhout; Karin Hummel; Marc C Willemsen; Mohammad Siahpush; Anton E Kunst; Hein de Vries; Geoffrey T Fong; Bas van den Putte
Journal:  Drug Alcohol Depend       Date:  2014-04-28       Impact factor: 4.492

2.  Beliefs, experience, and interest in pharmacotherapy among smokers with HIV.

Authors:  Amy McQueen; Enbal Shacham; Walton Sumner; E Turner Overton
Journal:  Am J Health Behav       Date:  2014-03

3.  Effect of a mobile phone intervention on quitting smoking in a young adult population of smokers: randomized controlled trial study protocol.

Authors:  Neill Bruce Baskerville; Laura Louise Struik; David Hammond; G Emmanuel Guindon; Cameron D Norman; Robyn Whittaker; Catherine M Burns; Kelly A Grindrod; K Stephen Brown
Journal:  JMIR Res Protoc       Date:  2015-01-19

Review 4.  Why do smokers try to quit without medication or counselling? A qualitative study with ex-smokers.

Authors:  Andrea L Smith; Stacy M Carter; Simon Chapman; Sally M Dunlop; Becky Freeman
Journal:  BMJ Open       Date:  2015-04-30       Impact factor: 2.692

5.  A Pilot Randomized Clinical Trial of Remote Varenicline Sampling to Promote Treatment Engagement and Smoking Cessation.

Authors:  Matthew J Carpenter; Kevin M Gray; Amy E Wahlquist; Karen Cropsey; Michael E Saladin; Brett Froeliger; Tracy T Smith; Benjamin A Toll; Jennifer Dahne
Journal:  Nicotine Tob Res       Date:  2021-05-24       Impact factor: 4.244

6.  Group hypnosis vs. relaxation for smoking cessation in adults: a cluster-randomised controlled trial.

Authors:  Maria Dickson-Spillmann; Severin Haug; Michael P Schaub
Journal:  BMC Public Health       Date:  2013-12-23       Impact factor: 3.295

7.  Role of e-cigarettes and pharmacotherapy during attempts to quit cigarette smoking: The PATH Study 2013-16.

Authors:  John P Pierce; Tarik Benmarhnia; Ruifeng Chen; Martha White; David B Abrams; Bridget K Ambrose; Carlos Blanco; Nicolette Borek; Kelvin Choi; Blair Coleman; Wilson M Compton; K Michael Cummings; Cristine D Delnevo; Tara Elton-Marshall; Maciej L Goniewicz; Shannon Gravely; Geoffrey T Fong; Dorothy Hatsukami; James Henrie; Karin A Kasza; Sheila Kealey; Heather L Kimmel; Jean Limpert; Raymond S Niaura; Carolina Ramôa; Eva Sharma; Marushka L Silveira; Cassandra A Stanton; Michael B Steinberg; Ethel Taylor; Maansi Bansal-Travers; Dennis R Trinidad; Lisa D Gardner; Andrew Hyland; Samir Soneji; Karen Messer
Journal:  PLoS One       Date:  2020-09-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.